PB1888: TRIAL IN PROGRESS: PHASE 1B/2 STUDY OF PIVEKIMAB SUNIRINE (PVEK, IMGN632) IN COMBINATION WITH VENETOCLAX/AZACITIDINE OR MAGROLIMAB FOR PATIENTS WITH CD123-POSITIVE ACUTE MYELOID LEUKEMIA (AML)

• Naval Daver,
• Pau Montesinos,
• Ahmed Aribi,
• Giovanni Martinelli,
• Eunice Wang,
• Jessica Altman,
• Gail Roboz,
• Patrick Burke,
• Roland Walter,
• Kebede Benga,
• Callum Sloss,
• Kara Malcolm,
• Patrick Zweidler-Mckay,
• Kendra Sweet

Affiliations

Naval Daver

1 MD Anderson Cancer Center, Houston, United States

Pau Montesinos

2 Hospital Universitari i Politècnic La Fe, Valencia, Spain

Ahmed Aribi

3 City of Hope, Duarte, United States

Giovanni Martinelli

4 IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” IRST S.r.l., Meldola, Italy

Eunice Wang

5 Roswell Park Comprehensive Cancer Center, Buffalo, United States

Jessica Altman

6 Northwestern University, Chicago, United States

Gail Roboz

7 Weill Cornell Medical College, New York, United States

Patrick Burke

8 University of Michigan, Ann Arbor, United States

Roland Walter

9 Fred Hutchinson Cancer Center, Seattle, United States

Kebede Benga

10 Mayo Clinic, Rochester, United States

Callum Sloss

11 ImmunoGen, Inc, Waltham, United States

Kara Malcolm

11 ImmunoGen, Inc, Waltham, United States

Patrick Zweidler-Mckay

11 ImmunoGen, Inc, Waltham, United States

Kendra Sweet

12 H. Lee Moffitt Cancer Center and Research Institute, Tampa, United States